Decreased IDO activity and increased TTS expression break immune tolerance in patients with immune thrombocytopenia

Journal of Clinical Immunology

Volumn 31, Issue 4, 2011, Pages 643-649

  Wang, Chun Yan ^a,c   Shi, Yan ^a   Min, Ya Nan ^a   Zhu, Xiao Juan ^a,d   Guo, Cheng Shan ^c   Peng, Jun ^a,b   Dong, Xiao Yuan ^a   Qin, Ping ^a   Sun, Jian Zhi ^a   Hou, Ming ^a,b  

^a SHANDONG UNIVERSITY   (China)

^b BEIJING HOSPITAL   (China)

^c THE SECOND HOSPITAL OF SHANDONG UNIVERSITY   (China)

^d SHANDONG UNIVERSITY   (China)

Author keywords

Immune thrombocytopenic purpura; Indoleamine 2,3 dioxygenase; TryptophanyltRNA synthetase

Indexed keywords

INDOLEAMINE 2,3 DIOXYGENASE; KYNURENINE; MESSENGER RNA; TRYPTOPHAN TRANSFER RNA LIGASE;

ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; CD19+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL SUBPOPULATION; CLINICAL ARTICLE; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME DEGRADATION; FEMALE; HUMAN; IMMUNE THROMBOCYTOPENIA; IMMUNOLOGICAL TOLERANCE; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; THROMBOCYTOPENIA;

ADULT; AGED; ANTIGENS, CD14; ANTIGENS, CD19; AUTOIMMUNE DISEASES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HUMANS; IMMUNE TOLERANCE; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; KYNURENINE; MALE; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; THROMBOCYTOPENIA; TRYPTOPHAN; TRYPTOPHAN-TRNA LIGASE;

EID: 80555126844     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-011-9525-7     Document Type: Article

References (31)

1. McMillan R. The pathogenesis of chronic immune thrombocytopenic purpura. Semin Hematol. 2007;44(4 suppl 5):S3-S11. (Pubitemid 350256798)
2. Gernsheimer T. Chronic idiopathic thrombocytopenic purpura: Mechanisms of pathogenesis. Oncologist. 2009;14:12-21.
3. Mellor AL, Keskin DB, Johnson T, Chandler P, Munn DH. Cells expressing indoleamine 2,3-dioxygenase inhibit T cell responses. J Immunol. 2002;168:3771-6. (Pubitemid 34298376)
4. Munn DH, Sharma MD, Lee JR, Jhaver KG, Johnson TS, Keskin DB, et al. Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase. Science. 2002;297:1867-70. (Pubitemid 35024345)
5. Fallarino F, Grohmann U, Vacca C, Bianchi R, Orabona C, Spreca A, et al. T cell apoptosis by tryptophan catabolism. Cell Death Differ. 2002;9:1069-77.
6. Frumento G, Rotondo R, Tonetti M, Damonte G, Benatti U, Ferrara GB. Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase. J Exp Med. 2002;196:459-68.
7. von Rango U. Fetal tolerance in human pregnancy-A crucial balance between acceptance and limitation of trophoblast invasion. Immunol Lett. 2008;115:21-32.
8. Jia L, Tian P, Ding C. Immunoregulatory effects of indoleamine 2, 3-dioxygenase in transplantation. Transpl Immunol. 2009;21:18-22.
9. Munn DH, Mellor AL. Indoleamine 2,3-dioxygenase and tumorinduced tolerance. J Clin Invest. 2007;117:1147-54.
10. Friberg M, Jennings R, Alsarraj M, Dessureault S, Cantor A, Extermann M, et al. Indoleamine 2,3-dioxygenase contributes to tumor cell evasion of T cell-mediated rejection. Int J Cancer.2002;101:151-5. (Pubitemid 34970907)
11. Munn DH, Sharma MD, Hou D, Baban B, Lee JR, Antonia SJ, et al. Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes. J Clin Invest.2004;114:280-90. (Pubitemid 39071633)
12. Grohmann U, Fallarino F, Bianchi R, Orabona C, Vacca C, Fioretti MC, et al. A defect in tryptophan catabolism impairs tolerance in nonobese diabetic mice. J Exp Med. 2003;198:153-60. (Pubitemid 36870195)
13. Sakurai K, Zou JP, Tschetter JR, et al. Effect of indoleamine 2,3- dioxygenase on induction of experimental autoimmune encephalomyelitis. J Neuroimmunol. 2002;129(1-2):186-96. (Pubitemid 34874924)
14. Wang S, Mao C, Zhao Z, Gu Q, Jin M, Xiao Y, et al. Increased TTS abrogates IDO-mediated CD4+ T cells suppression in patients with Graves' disease. Endocr. 2009;36:119-25.
15. Zhu L, Ji F, Wang Y, Zhang Y, Liu Q, Zhang JZ, et al. Synovial autoreactive T cells in rheumatoid arthritis resist IDO-mediated inhibition. J Immunol. 2006;177:8226-33. (Pubitemid 44846344)
16. Fleckner J, Martensen PM, Tolstrup AB, Kjeldgaard NO, Justesen J. Differential regulation of the human, interferon inducible tryptophanyl-tRNA synthetase by various cytokines in cell lines. Cytokine. 1995;7:70-7.
17. Murray MF. Tryptophan depletion and HIV infection: A metabolic link to pathogenesis. Lancet Infect Dis. 2003;3:644-52. (Pubitemid 37210228)
18. Boasso A, Herbeuval JP, Hardy AW, Winkler C, Shearer GM. Regulation of indoleamine 2,3-dioxygenase and tryptophanyltRNA- synthetase by CTLA-4-Fc in human CD4+ T cells. Blood.2005;105:1574-81. (Pubitemid 40223677)
19. Rodeghiero F, Stasi R, Gernsheimer T, Michel M, Provan D, Arnold DM, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: Report from an international working group. Blood.2009;113:2386-93.
20. Widner B, Werner ER, Schennach H, Wachter H, Fuchs D. Simultaneous measurement of serum tryptophan and kynurenine by HPLC. Clin Chem. 1997;43:2424-6. (Pubitemid 28022985)
21. Semple JW, Milev Y, Cosgrave D, Mody M, Hornstein A, Blanchette V, et al. Differences in serum cytokine levels in acute and chronic autoimmune thrombocytopenic purpura: Relationship to platelet phenotype and antiplatelet T-cell reactivity. Blood.1996;87:4245-54. (Pubitemid 26152268)
22. Guo C, Chu X, Shi Y, He W, Li L, Wang L, et al. Correction of Th1-dominant cytokine profiles by high-dose dexamethasone in patients with chronic idiopathic thrombocytopenic purpura. J Clin Immunol. 2007;27:557-62.
23. Thomas SR, Terentis AC, Cai H, Takikawa O, Levina A, Lay PA, et al. Post-translational regulation of human indoleamine 2,3- dioxygenase activity by nitric oxide. J Biol Chem.2007;282:23778-87. (Pubitemid 47328013)
24. Munn DH, Sharma MD, Mellor AL. Ligation of B7-1/B7-2 by human CD4(+) T cells triggers indoleamine 2,3-dioxygenase activity in dendritic cells. J Immunol. 2004;172:4100-10. (Pubitemid 38375222)
25. Thomas SR, Salahifar H, Mashima R, Hunt NH, Richardson DR, Stocker R. Antioxidants inhibit indoleamine 2,3-dioxygenase in IFN-g-activated human macrophages: Posttranslational regulation by pyrrolidine dithiocarbamate. J Immunol. 2001;166:6332-40. (Pubitemid 32440766)
26. Kudo Y, Boyd CA. Characterization of L-tryptophan transporters in human placenta: A comparison of brush border and basal membrane vesicles. J Physiol. 2001;531:405-16. (Pubitemid 32229666)
27. Praetorius-Ibba M, Stange-Thomann N, Kitabatake M, Ali K, Söll I, Carter Jr CW, et al. Ancient adaptation of the active site of tryptophanyl-tRNA synthetase for tryptophan binding. Biochemistry.2002;39:13136-41.
28. Kudo Y, Boyd CA. Human placental indoleamine 2,3-dioxygenase: Cellular localization and characterization of an enzyme preventing fetal rejection. Biochim Biophys Acta. 2000;1500:119-24. (Pubitemid 29525405)
29. Rubin BY, Anderson SL, Xing L, Powell RJ, Tate WP. Interferon induces tryptophanyl-tRNA synthetase expression in human fibroblasts. J Biol Chem. 1991;266:24245-8. (Pubitemid 21908932)
30. Tolstrup AB, Bejder A, Fleckner J, Justesen J. Transcriptional regulation of the interferon-gamma-inducible tryptophanyl-tRNA synthetase includes alternative splicing. J Biol Chem.1995;270:397-403.
31. Jorgensen R, Sogaard TM, Rossing AB, Martensen PM, Justesen J. Identification and characterization of human mitochondrial tryptophanyl-tRNA synthetase. J Biol Chem. 2000;275:16820-6. (Pubitemid 30398916)